Genomics company Illumina Inc. reports increased revenue in the second quarter of 2015 in its Q2 financial results.
Revenue was $539 million, a 21 percent increase compared to $448 million in the second quarter of 2014, and an increase of 25 percent on a constant currency basis.
“We delivered solid financial results in the second quarter with increasing demand for our new products,” says chief executive officer Jay Flatley. “The fundamentals of our business are strong and we remain focused on innovation and market expansion.”
More information is available here: http://www.illumina.com/company/news-center/press-releases/press-release-details.html?newsid=2069666
